Skip to main content
    I

    Inspire Medical Systems Inc (INSP)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $59.44
    +0.31 (+0.53%)

    Market Cap: $1.71B

    Last updated: Nov 17, 2026 at 4:17 PM ET

    Inspire Medical Systems Inc (INSP) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Inspire Medical Systems (INSP) has a market cap of $1.71B and an enterprise value of $1.52B. It holds $190.80M more cash than debt, 11.14% of its market cap.

    Total Valuation

    Enterprise value is 11.14% below the market cap, as cash exceeds debt.

    Market Cap$1.71B
    Enterprise Value$1.52B
    Latest price (Nov 17, 2026)$59.44

    Key Dates

    The next earnings report is expected on May 3, 2027, covering the quarter ending Mar 31, 2027.

    Next Earnings DateMay 3, 2027 (expected)
    Last Earnings DateNov 2, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.33% in the quarter ended Sep 30, 2026 and shrank 1.60% a year over 2 years.

    Shares Outstanding28.93M
    Shares Change (YoY)-1.37%
    Shares Change (QoQ)+0.33%
    Share Count Growth (2Y CAGR)-1.60%

    Valuation Ratios

    Sales and book value multiples are 2.0x and 2.1x.

    P/E Ratio29.3x
    P/S Ratio2.0x
    Forward P/S2.0x
    P/B Ratio2.1x
    P/FCF Ratio17.6x
    P/OCF Ratio12.7x
    PEG Ratio1.4

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 46.4x EBITDA and 15.6x free cash flow.

    EV / Earnings15.1x
    EV / Sales1.7x
    EV / EBITDA46.4x
    EV / FCF15.6x

    Price Statistics

    The stock is down 31.17% over 52 weeks and trades 13.63% below its 50-day average.

    Beta (1Y)0.92
    52-Week Change-31.17%
    1-Month Change-15.27%
    3-Month Change-3.66%
    6-Month Change+39.75%
    5-Year Change-74.74%
    Total Return (1Y)-31.17%
    Total Return (3Y CAGR)-24.88%
    Total Return (5Y CAGR)-25.88%
    Return vs SPY (1Y)-40.44%
    Max Drawdown (1Y)-72.19%
    Max Drawdown (3Y)-84.06%
    Sharpe Ratio (1Y)-0.50
    Correlation with SPY (1Y)0.18
    50-Day Average$68.82
    200-Day Average$57.29
    52-Week Range$38.91 to $147.03
    RSI (14 Days)34.3
    Average Volume (20 Days)673.50K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 6.45x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio6.45x
    Quick Ratio4.61x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 12.18% over the last 12 months, against a 5-year average of -0.94%.

    Return on Equity (ROE)12.18%
    Return on Assets (ROA)10.57%
    ROE (5Y Average)-0.94%
    ROA (5Y Average)-0.53%
    ROIC (5Y Average)-4.78%
    Asset Turnover1.00x
    Inventory Turnover0.70x
    Receivables Turnover8.47x
    Cash Conversion Cycle469 days

    Scores

    INSP has an Altman Z-Score of 9.56, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score9.56
    Altman Z ZoneSafe
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $880.94M over the last 12 months is down 0.19% from the 12 months before.

    Revenue$880.94M
    Revenue Growth (YoY)-0.19%
    Gross Profit$759.24M
    Operating Income$15.76M
    Pretax Income$30.82M
    Net Income$100.72M
    EBITDA$32.96M
    Reported EPS (TTM)$2.03

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 86.77% of the $953.03M in total assets.

    Cash and Equivalents$190.80M
    Total Debt$0
    Net Cash$190.80M
    Net Cash Per Share$6.60
    Working Capital$530.29M
    Shareholder Equity$826.95M
    Book Value Per Share$28.59
    Total Assets$953.03M
    Total Liabilities$126.08M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $37.08M of capital spending, operating cash flow left $97.89M of free cash flow.

    Operating Cash Flow$134.97M
    Capital Expenditures$37.08M
    Free Cash Flow$97.89M
    FCF Per Share$3.39
    Depreciation and Amortization$19.95M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 1.79%, against a 5-year average of -5.02%.

    Gross Margin86.19%
    Operating Margin1.79%
    Pretax Margin3.50%
    Net Margin11.43%
    EBITDA Margin3.74%
    FCF Margin11.11%
    Gross Margin (5Y Average)84.83%
    Operating Margin (5Y Average)-5.02%
    Net Margin (5Y Average)-1.96%

    Growth

    Revenue grew 30.77% a year over 3 years.

    Revenue Growth (3Y CAGR)+30.77%
    Revenue Growth (5Y CAGR)+51.21%
    FCF Growth (3Y CAGR)+216.60%
    Book Value Per Share Growth (2Y CAGR)+18.83%
    Tangible Book Per Share Growth (2Y CAGR)+18.83%

    Revenue and profit by year

    Dividends and Yields

    INSP does not pay a dividend. Its free cash flow yield is 5.69%.

    Earnings Yield3.41%
    FCF Yield5.69%
    Buyback Yield2.81%
    Shareholder Yield2.81%

    Peer Position

    Against 7 similar companies, INSP has the 4th highest P/E.

    P/E Ratio29.3x vs 10.2x median
    P/S Ratio2.0x vs 2.7x median
    Revenue Growth (Trailing 4 Quarters, YoY)-0.19% vs +11.95% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -1.89% and EPS growth at -23.85% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-1.89%
    EPS Growth Forecast (2Y CAGR)-23.85%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About INSP

    What is INSP's market cap?

    Inspire Medical Systems has a market cap of $1.71B. Its enterprise value, which adds debt and subtracts cash, is $1.52B.

    What is INSP's P/E ratio?

    Inspire Medical Systems has a trailing P/E ratio of 29.3x.

    How many shares of INSP are outstanding?

    Inspire Medical Systems has 28.93M shares outstanding. The count is down 1.37% from a year earlier.

    Does INSP pay a dividend?

    No. Inspire Medical Systems does not pay a dividend.

    How much debt does INSP have?

    Inspire Medical Systems has $0 of total debt and $190.80M of cash and equivalents, a net cash position of $190.80M.